Pseudomonas Aeruginosa Infection Market is segmented By Drug (Monoclonal Antibody, Small Molecule, Peptide), By Route of Administration (Oral, Parenteral, Topical), By Infection (Respiratory Infections, Urinary Tract Infections (UTIs)), By Patient Type (Hospital-acquired Infections, Community-acquired Infections), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Billion) for the above-mentioned.
The major players operating in the pseudomonas aeruginosa infection market include AstraZeneca, Pfizer, Merck & Co., Novartis, Basilea Pharmaceutica, Armata Pharmaceuticals, Spexis, AvidBiotics Corp, Polyphor AG, and Phico Therapeutics.
Pseudomonas Aeruginosa Infection Market